Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer.

M Peckham1

  • 1British Postgraduate Medical Federation, London, England.

Acta Oncologica (Stockholm, Sweden)
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Testicular cancer is the most common malignancy in young men, but advances in chemotherapy have dramatically improved cure rates for advanced disease. Most patients are now potentially curable, with fertility often preserved post-treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

6th Abercrombie symposium on cell motility. Introduction.

Journal of microscopy·2008
Same author

Engineering a multi-nucleated myotube, the role of the actin cytoskeleton.

Journal of microscopy·2008
Same author

Novel murine clonal cell lines either express slow or mixed (fast and slow) muscle markers following differentiation in vitro.

Developmental dynamics : an official publication of the American Association of Anatomists·2008
Same author

Cell biochemistry studied by single-molecule imaging.

Biochemical Society transactions·2006
Same author

Imaging myosin 10 in cells.

Biochemical Society transactions·2004
Same author

Microtubule assembly in cultured myoblasts and myotubes following nocodazole induced microtubule depolymerisation.

Journal of muscle research and cell motility·2003
Same journal

Overall survival following palliative immune checkpoint inhibitor treatment according to ECOG performance status: a large registry-based study.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Starshot field configuration in the linac isocentre size determination: a comparison of film and electronic portal imaging device measurements.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Perspectives on artificial intelligence-generated chronic disease risk predictions in early breast cancer: an international survey among radiation oncologists.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles

Area of Science:

  • Oncology
  • Urology
  • Men's Health

Background:

  • Testicular cancer is the most common malignancy in men aged 20-34.
  • Etiology remains largely unknown, but management has seen dramatic empirical advances.

Purpose of the Study:

  • To review the significant advancements in testicular cancer management.
  • To highlight the improved cure rates and evolving treatment strategies.

Main Methods:

  • Review of historical and current treatment outcomes for testicular cancer.
  • Analysis of the impact of chemotherapy on cure rates and subsequent management.
  • Assessment of fertility and psycho-social aspects in testicular cancer patients.

Main Results:

Related Experiment Videos

  • Cure rates for metastatic non-seminomatous germ cell tumors increased from <10% to ~90% with chemotherapy since the 1970s.
  • Chemotherapy has led to revised roles for surgery and radiotherapy, and surveillance policies.
  • Surgery for residual masses post-chemotherapy is needed in ~25% of advanced cases.
  • Most patients with prior spermatogenesis recover function; no increased risk of malformation in offspring.
  • Significant psycho-social morbidity persists despite excellent cure rates.

    • Conclusions:

    • Testicular cancer management has transformed, offering high cure rates, particularly for advanced disease.
    • Fertility is generally preserved post-treatment, with no increased risk to offspring.
    • Addressing psycho-social morbidity is crucial for comprehensive patient care.